Discovery and development of new biological drugs addressing significant unmet medical needs in the areas of difficult-to-treat diseases (e.g., cancers, inflammatory/immune disease, and rare diseases) More
Using its unique technology, biopharmaceutical company, Aptagen develops targeted drugs and licenses out new drugs to global pharmaceutical companies. More
The SETsquared Partnership is the collaboration of the Universities of Bath, Bristol, Southampton and Surrey, generating successful enterprise and entrepreneurship in southern England. More